Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Ducommun
DCO
$3.13B
| $2.45M | ﹤0.01% |
56,848
+20,549
| +57% | +$985K |
|
5052
CALL
TAL Education Group
TAL
$6.46B
| $2.45M | ﹤0.01% |
502,500
-142,300
| -22% | -$544K |
|
5053
A.O. Smith
AOS
$8.45B
| $2.44M | ﹤0.01% |
44,701
-61,517
| -58% | -$3.69M |
|
|
CRON
5054
PUT
Cronos Group
CRON
$1.16B
| $2.44M | ﹤0.01% |
866,500
+514,300
| +146% | +$1.6M |
|
5055
PUT
Masco
MAS
$14.7B
| $2.44M | ﹤0.01% |
48,300
-196,000
| -80% | -$10.4M |
|
5056
PUT
LiveRamp
RAMP
$2.3B
| $2.44M | ﹤0.01% |
94,700
+83,700
| +761% | +$2.48M |
|
5057
PUT
ArcBest
ARCB
$3.19B
| $2.44M | ﹤0.01% |
34,700
+11,200
| +48% | +$824K |
|
5058
Elbit Systems
ESLT
$36.7B
| $2.44M | ﹤0.01% |
10,646
+7,848
| +280% | +$1.64M |
|
5059
Direxion Daily Regional Banks Bull 3X ETF
DPST
$417M
| $2.44M | ﹤0.01% |
+10,129
| New | +$3.13M |
|
|
FLG
5060
Flagstar Bank National Association
FLG
$5.92B
| $2.44M | ﹤0.01% |
89,105
-787,852
| -90% | -$22.7M |
|
|
AMWD
5061
DELISTED
American Woodmark
AMWD
| $2.44M | ﹤0.01% |
54,150
+2,477
| +5% | +$120K |
|
5062
AZZ Inc
AZZ
$4.55B
| $2.44M | ﹤0.01% |
59,734
+25,019
| +72% | +$1.12M |
|
5063
CALL
National Beverage
FIZZ
$2.93B
| $2.44M | ﹤0.01% |
49,800
-3,400
| -6% | -$159K |
|
5064
iShares US Industrials ETF
IYJ
$1.97B
| $2.43M | ﹤0.01% |
27,611
-2,484
| -8% | -$239K |
|
5065
AtriCure
ATRC
$2.25B
| $2.43M | ﹤0.01% |
59,503
-151,745
| -72% | -$7.19M |
|
5066
CALL
Jones Lang LaSalle
JLL
$17.3B
| $2.43M | ﹤0.01% |
13,900
-5,400
| -28% | -$1.08M |
|
5067
PUT
Warner Music
WMG
$13.4B
| $2.43M | ﹤0.01% |
99,800
+47,600
| +91% | +$1.42M |
|
5068
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
| $2.43M | ﹤0.01% |
50,233
+33,117
| +193% | +$1.68M |
|
|
DM
5069
PUT
DELISTED
Desktop Metal, Inc.
DM
| $2.43M | ﹤0.01% |
110,465
+20,312
| +23% | +$594K |
|
5070
PUT
LivePerson
LPSN
$35.1M
| $2.43M | ﹤0.01% |
11,440
-1,740
| -13% | -$489K |
|
5071
ProShares UltraPro S&P 500
UPRO
$5.78B
| $2.42M | ﹤0.01% |
+69,553
| New | +$3.24M |
|
5072
PUT
Cognex
CGNX
$11B
| $2.42M | ﹤0.01% |
57,000
+44,600
| +360% | +$2.5M |
|
5073
CALL
GoPro
GPRO
$110M
| $2.42M | ﹤0.01% |
438,100
+95,500
| +28% | +$698K |
|
5074
CALL
Levi Strauss
LEVI
$8.68B
| $2.42M | ﹤0.01% |
148,400
-88,700
| -37% | -$1.6M |
|
5075
PUT
Freshworks
FRSH
$3.5B
| $2.42M | ﹤0.01% |
184,000
-65,500
| -26% | -$1.02M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.